Investing Profile

David Fallace

InvestorVCFounder

Managing Partner and Co-founder at Cure Ventures

curevc.comMassachusetts

Your Intro Paths to David Fallace

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks David is a member of

Polaris Partners Network

30 CONNECTIONS

Polaris Venture Partners Network

24 CONNECTIONS

Find David Fallace on

Current Investing Position

Cure Ventures Managing Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

David Fallace is on these Sector & Stage Rankings

David Fallace's Investments On Record (1)

Company	StageDateRound Size	Total Raised
Kenai Therapeutics	Series AFeb 2024$82M	$82M
Co-investors: Jeff Goater (The Column Group)

David Fallace's Experience

Managing Partner and Co-founder Cure Ventures2021 - Present

Board Observer Juno Therapeutics, Inc.Present

Investor Haugen Financial SystemsPresent

Managing Director TIFF Investment ManagementPresent

Adviser Polaris Venture PartnersPresent

Adviser Polaris Partners2018 - 2019

Managing Director The Investment Fund for Foundations2016 - 2017

Investor Codiak Biosciences2015 - 2016

Board Observer Denali Therapeutics2015 - 2016

Director - Special Opportunities Alaska Permanent Fund Corporation2013 - 2016

Board Observer Juno Therapeutics2013 - 2014

Vice President Haugen Financial Systems2009 - 2013

Vice President GF Private Equity Group2000 - 2009

David Fallace's Education

University at Buffalo School of Law Juris Doctor Tax and Financial Transactions

State University of New York at Buffalo - Law School Juris Doctor Tax and Financial Transactions

University at Buffalo School of Management, The State University of New York MBA Finance

Investors who invest with David Fallace

Scouts & Angels Affiliated With David Fallace